MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
Investment in securities market are subject to market risks. Read all the related documents carefully before investing
The Rally of the Past 5 Years was Just a Preview of...
Peak India
Grab this Opportunity Before it Catches More Momentum
Starting With Our 3 High-potential Stock Recommendations
- Home
- Outlook Arena
- Pharma Sector Penny Stocks
Pharma Sector Penny Stocks
Globally, India has the lowest manufacturing costs in the pharma sector. This ability to manufacture high quality and low-priced medicines, presents a huge business opportunity for the domestic industry.
India's cost of production is approximately 33% lower than that of the US.
Over the years, domestic pharma manufacturers have experienced a significant increase in R&D spending to be competitive in the world market.
The Covid-19 pandemic may as well turn out to be a blessing in disguise for pharma companies as it pushed them to expedite focus on various pharma segments.
Further, pharma companies' efforts have been supplemented by the government's production-linked incentive (PLI) scheme.
All of this puts the top pharma companies in India in a sweet spot.
However, the opportunities are not just limited to the big pharma companies. Even their smaller counterparts can make a breakthrough and get recognized.
If the smaller companies do have a major impact in the future, the pharma sector penny stocks could turn into future bluechips.
Here are some of the pharma sector penny stocks to add to your watchlist.
- Alembic Ltd.
- Morepen Laboratories Ltd.
- Syncom Formulations (India) Ltd.
- Rajnish Wellness Ltd.
- Nectar Lifesciences Ltd.
- Medico Remedies Ltd.
- Zenotech Laboratories Ltd.
- Ambalal Sarabhai Enterprises Ltd.
- Gennex Laboratories Ltd.
- Syschem (India) Ltd.
- Sudarshan Pharma Industries Ltd.
- Kimia Biosciences Ltd.
- Lasa Supergenerics Ltd.
- Krebs Biochemicals & Industries Ltd.
- Bharat Immunologicals & Biologicals Corporation Ltd.
These companies could become the best pharma stocks in India.
Since pharma stocks interest you, check out our list of pharma stocks which has Indian pharma stocks and MNC pharma stocks.
You can also checkout our playlist on Pharma Stocks on Equitymaster's YouTube channel.
![]()
3 Biopharma Stocks to Watch Amid the Rs 100 Billion Biopharma Shakti Scheme
Feb 1, 2026
With Budget 2026 announcing a biopharma scheme, here are three stocks investors should closely watch.
![]()
Why Dr Reddys Share Price is Rising
Dec 20, 2024
Here's how positive outlook is driving the rally in this pharma company's share price.
![]()
Why Indian Pharma Stocks Should be on Your Watchlist
Aug 9, 2024
A major megatrend is playing out in the pharma sector.
![]()
Orchid Pharma's Most Important Medical Advance in 32 Years
Jun 20, 2024
Here's how Orchid Pharma's new antibiotic approval could transform the company.
![]()
Why Glenmark Pharma Share Price is Rising
May 29, 2024
Find out why this pharma company's share price touched it 52-week high
![]()
Beyond Pharma: Top 10 Medical Equipment Stocks to Add to Your Watchlist
Mar 11, 2024
Pharma companies won't be the only ones to benefit as the sector grows. Medical equipment stocks could also come into play.
![]()
Why Glenmark Pharma Share Price is Rising
Oct 3, 2023
Glenmark Pharma shares surge 10% in a day. What's driving the rally?
![]()
Yatharth Hospital IPO: 5 Things to Know
Jul 25, 2023
From grey market premium to price band, here's everything you need to know about the upcoming IPO.
![]()
Why Sun Pharma Share Price is Falling
May 11, 2023
The company's shares have plummeted 5% in a month. More details inside.
![]()
3 Caveats Before Considering the Mankind Pharma IPO
Apr 25, 2023
Every domestic pharma stock in India must contend with these woes.
![]()
Everyone Knows About Dr Reddy's Lab, Cipla and Sun Pharma. But Here are 5 Pharma Stocks Flying Under the Radar
Aug 2, 2025
Here are 5 lesser-known companies from the pharma industry.
![]()
Ashish Kacholia Picks Stake in Multibagger Pharma Stock
Nov 12, 2024
Here's why the seasoned investor added this pharma stock that has gained 168% in the past year.
![]()
Ace Investor Mukul Agrawal Adds More Stake in a Smallcap Pharma Stock
Jul 25, 2024
Here's why the seasoned investor turn bullish on this pharma stock.
![]()
Why Divi's Laboratories Share Price is Rising
May 30, 2024
Find out the reasons behind the pharma company's recent share price rally.
![]()
Rajnish Wellness: A Backdoor Play to Profit from India's Railway Boom
Apr 11, 2024
This pharma sector penny stock is taking a giant leap in developing medical facilities at railways stations.
![]()
5 Best Pharma Penny Stocks in India
Mar 3, 2024
India's ability to manufacture high quality and low-priced medicines presents a huge business opportunity for these pharma sector penny stocks.
![]()
Why Navin Fluorine Share Price is Falling
Sep 29, 2023
Shares of Navin Fluorine tanked 13% today. Read on to find out why.
![]()
Why Dr Reddy's Lab Share Price is Falling
May 12, 2023
Dr Reddy's Lab shares tumbled 5%, even after reporting a ten-fold jump in Q4 net profit. Here's why.
![]()
Are Bitter Days Over for Pharma Stocks?
Apr 28, 2023
Has the pharma sector bottomed out? Find out as I decode the opportunity in the pharma sector.
![]()
Pharma Stocks: Is a Re-rating on the Cards?
Apr 20, 2023
Are the bitter days over for the Indian pharma sector? Here's what lies ahead.
FAQs
Which are the top pharma companies in India?
Based on marketcap, these are the top pharma companies in India:
You can see the full list of pharmaceuticals stocks here.
And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for top pharma companies in India .
What are the top gainers and top losers within the pharma sector today?
Within the Pharmaceuticals sector, the top gainers were ASPIRA PATHLAB & DIAGNOSTICS (up 11.7%) and VANTA BIOSCIENCE (up 10.8%). On the other hand, ADESHWAR MEDITEX (down 15.0%) and MURAE ORGANISOR LTD. - (RIGHTS ENTITLEMENTS (RES)) (down 12.5%) were among the top losers.
For more, please check out our pharma sector report.
Where can I find a list of pharma stocks?
The details of listed pharma companies can be found on the NSE and BSE website.
For a more curated list, you can check out our list of pharma stocks which has Indian pharma stocks and MNC pharma stocks.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
- Hidden Treasure
- Forever Stocks
- Big Wave Profits
- Equitymaster Venture
- Microcap Millionaires
- Momentum Profits
- Double Income
- Midcap Value Alert
- Exponential Profits
- Annual Breakout Alert
- Lazy Millionaire
- Phase One Alert
- InsiderPro Stocks
- StockSelect
- Private Briefing
- Active Wealth Multiplier 2030
- FundSelect
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
- Best Defence Stocks in India
- Upcoming Dividend Stocks
- Best Semiconductor Stocks in India
- Data Center Stocks in India
- Best Railway Stocks in India
- Best Solar Stocks in India
- Fastest Growing Stocks in India
- List of BSE Sensex 30 Stocks
- Adani Group Shares
- Stocks Recently Bought by FIIs in India
- Top Value Stocks in India
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, enlistment with BSE as IA and RA, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing any content from this website whether wholly or in part, for any purpose without the permission of Quantum Information Services Private Limited is strictly prohibited and shall be deemed to be copyright infringement.
Quantum Information Services Private Limited (QIS) is a SEBI registered Research Analyst (bearing registration no INH000021128) and Investment Adviser(Reg. No: INA000000680). Consequent upon the merger of Equitymaster Research Private Limited into QIS, effective October 30, 2025 QIS owns and operates brand 'Equitymaster' and website www.equitymaster.com. This does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities and QIS including its employees, personnel, directors, associates will not be liable for any losses (direct or indirect) incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. All content and information is provided on an 'As Is' basis by QIS. Information herein is believed to be reliable but QIS does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by QIS are on a best effort basis. QIS does not assure or guarantee the user any minimum or fixed returns. The securities quoted, if any are for illustration only and are not recommendatory. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject QIS or its affiliates to any registration or licensing requirement.
The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing QIS's content and website, you agree to our Terms and Conditions of Use, available here